newsfilter
← Latest News
Business Wire·

NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its second quarter 2025 financial results prior to the open of the